01.14.14
National Advertising Division (NAD), New York, NY, has called into question product claims made by COORGA Nutraceuticals Corporation for its Grey Defense dietary supplement. COORGA declined to respond to the NAD’s inquiry, and as a result the NAD has referred them to the Federal Trade Commission (FTC).
The NAD is an investigative unit of the advertising industry’s system of self-regulation, which is administered by the Council of Better Business Bureaus.
The NAD had requested substantiation for the following advertising claims:
· “Reverse Grey Hair in 6 Months”
· “Try Grey Defence Xtreme for 6 months, if the results don’t amaze, we’ll give you your money back”
· “Grey Defence is a super-premium dietary supplement that is formulated to assist the body in reversing gray hair due to oxidative stress”
· “Grey Defence neutralizes hydrogen peroxide on contact, helping to slow, stop and reverse grey hair due to oxidative stress”
In refusing NAD’s request for further information about the claims, the advertiser noted that its decision was rooted in its concern about publicly disclosing the research upon which the company relies to support its advertising claims.
In light of the advertiser’s position, the NAD, pursuant to Section 2.9 of the NAD/NARB Procedures, referred this matter to the FTC for possible law enforcement action.
The NAD is an investigative unit of the advertising industry’s system of self-regulation, which is administered by the Council of Better Business Bureaus.
The NAD had requested substantiation for the following advertising claims:
· “Reverse Grey Hair in 6 Months”
· “Try Grey Defence Xtreme for 6 months, if the results don’t amaze, we’ll give you your money back”
· “Grey Defence is a super-premium dietary supplement that is formulated to assist the body in reversing gray hair due to oxidative stress”
· “Grey Defence neutralizes hydrogen peroxide on contact, helping to slow, stop and reverse grey hair due to oxidative stress”
In refusing NAD’s request for further information about the claims, the advertiser noted that its decision was rooted in its concern about publicly disclosing the research upon which the company relies to support its advertising claims.
In light of the advertiser’s position, the NAD, pursuant to Section 2.9 of the NAD/NARB Procedures, referred this matter to the FTC for possible law enforcement action.